Covered recipient · General Payments record
JEREMY KARLIN
Allopathic & Osteopathic Physicians Radiology Radiation Oncology
General Payments · PY2021–2024
$2,407.50
- Reported across 22 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $1,575.00 | 3 |
| Food and Beverage | $353.98 | 5 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $1,575.00 | 3 |
| Teleflex LLC | $151.98 | 1 |
| Merck Sharp & Dohme Corporation | $106.30 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $53.34 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $27.70 | 1 |
| MEDTEC LLC | $14.66 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $525.00 | 06/25/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1104326016 | CMS |
| AstraZeneca Pharmaceuticals LP | $525.00 | 10/30/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105699610 | CMS |
| AstraZeneca Pharmaceuticals LP | $525.00 | 10/30/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105862594 | CMS |
| Boston Scientific Corporation | $53.34 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092342144 | CMS |
| MEDTEC LLC | $14.66 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146429926 | CMS |
| Merck Sharp & Dohme LLC | $106.30 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141715861 | CMS |
| Novartis Pharmaceuticals Corporation | $27.70 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087131364 | CMS |
| Teleflex LLC | $151.98 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142081664 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.